Encelimab (Anti-LAG3 / CD223)Encelimab (Anti-LAG3 / CD223)
Move your mouse over image or click to enlarge

Encelimab (Anti-LAG3 / CD223)

Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.
Cat# Size Price Qty Buy
A2993-1mg*25 1mg*25
£4,152.00
A2993-1mg*5 1mg*5
£1,384.00
A2993-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2993

Related Documents